The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input from 35 individuals, organizations, and companies during the initial public comment period. The agency did not specify any particular issues or deficiencies that it wants to address by updating its coverage policy, but CMS has not reconsidered the national coverage policy on ICDs since a major coverage expansion was implemented in 2005.
The US Centers for Medicare and Medicaid Services is considering updating its national coverage policy for implantable cardioverter defibrillators for the first time in twelve years.
The agency formally opened the review of its national coverage policy for ICDs – Section 20.4 of the...